322 Letters in Organic Chemistry, 2013, Vol. 10, No. 5
Shinde et al.
ꢀ-pyrones and two bicyclic tetrahydro-ꢀ-pyrone derivatives from
Cryptocarya latifolia. Phytochemistry, 1995, 38, 1427-1430; c)
Cavasheiro, A. J.; Yoshida, M. 6-[ꢂ-Arylalkenyl]-5,6-dihydro-ꢀ-
pyrones from Cryptocarya moschata (Lauraceae). Phytochemistry,
2000, 53, 811-819.
a) Hoffmann, H. M. R.; Rabe, J. Synthesis and biological activity
of ꢀ-methylene-ꢁ-butyrolactones. Angew. Chem. Int. Ed. Engl.,
1985, 24, 94-110; b) Antonio, M. A.; de Carvalho, J. E.; Pillia, R.
A. (R)-Goniothalamin: total syntheses and cytotoxic activity
against cancer cell lines. Bioorg. Med. Chem., 2005, 13, 2927-
2933.
Buck, S. B.; Hardouin, C.; Ichikawa, S.; Soenen, D. R.; Gauss, C.
M.; Hwang, I.; Swinkle, M. R.; Bonness, K. M.; Honkanen, R. E.;
Boger, D. L. Fundamental role of the fostriecin unsaturated lactone
and implications for selective protein phosphatase inhibition. J.
Am. Chem. Soc., 2003, 125, 15694-15695.
Marco, J. A.; Carda, M.; Murga, J.; Falomir, E. Stereoselective
syntheses of naturally occurring 5,6-dihydropyran-2-ones. Tetrahe-
dron, 2007, 63, 2929-2958.
a) Das, B.; Laxminarayana, K.; Krishnaiah, M.; Kumar, D. N.
Stereoselective total synthesis of a potent natural antifungal com-
pound (6S)-5,6,dihydro-6-[(2R)-2-hydroxy-6-phenyl hexyl]-2H-
pyran-2-one. Biorg. Med. Chem. Lett.; 2009, 19, 6396-6398; b)
Das, B.; Satyalakshmi, G.; Suneel, K.; Shinde, D. B. Stereoselec-
tive total synthesis of the piperidine alkaloids, (+)-coniine, (+)-
pseudoconhydrine, and (+)-sedamine through a common interme-
diate. Tetrahedron Asymmetry, 2011, 22, 1000-1005.
Ovedraogo, M.; Carreyre, H.; Vandelrouck, C.; Bescound, J.;
Raymond, G.; Guissou, I.-P.; Cognard, C.; Becq, F.; Potreau, D.;
Cousson, A.; Marrot, J.; Coustard, J.-M. Structure elucidation of a
dihydropyranone from Tapinanthus dodoneifolius. J. Nat. Prod.,
2007, 70, 2006-2009.
Maxwell, A.; Dabideen, D.; Reynolds, W. F.; McLean, S. Two 6-
substituted 5,6-dihydropyran-2-ones from Piper reticulatum. J.
Nat. Prod., 1998, 61, 815-816.
Meragelman, T. L.; Scudiero, D. A.; Davis, R. E.; Staudt, L. M.;
McCloud, T. G.; Cardellina, J. H. II.; Shoemaker, R. H. Inhibitors
of the NF-kB activation pathway from Cryptocarya rugulosa. J.
Nat. Prod., 2009, 72, 336-339.
Bohlmann, F.; Suwita, A. Ein neues bisabolen-derivat und ein
neues dihydro kaffeesäure-derivat aus Tarchonanthus trilobus.
Phytochemistry, 1979, 18, 677-678.
Raoelison, G. E.; Terreaux, C.; Queiroz, E. F.; Zsila, F.; Simonyi,
M.; Antus, S.; Randriantsoa, A.; Hostettmann, K. Absolute
configuration of two new 6-alkylated ꢀ-pyrones (2H-pyran-2-ones)
from Ravensara crassifolia. Helv. Chim. Acta, 2001, 84, 3470-
3476.
Berkowitz, B.; Huang, D.-B.; Chen-Park, F. E.; Sigler, P. B.;
Ghosh, G. The X-ray crystal structure of the NF-ꢃB p50·p65
heterodimer bound to the interferon ꢂ-ꢃB site. J. Bio. Chem., 2002,
277, 24694-24700.
a) Butler, C. L.; Clapp, M. J. The preparation of benzyloxyalkyl p-
toluenesulfonates. J. Am. Chem. Soc., 1938, 60, 1472-1473; b)
Crimmins, M. T.; Shamszad, M.; Anita, E.; Mattson, A, E. A
highly convergent approach toward (ꢄ)-brevenal. Org. lett., 2010,
12, 2614-2617.
Reddy, D. K.; Shekhar, V.; Reddy, T. S.; Reddy, S. P.; Venkates-
warlu, Y. Stereoselective first total synthesis of (R)-rugulactone.
Tetrahedron Asymmetry, 2009, 20, 2315-2319.
a) Hanawa, H.; Hashimoto, T.; Maruoka, K. Bis(((S)-
binaphthoxy)(isopropoxy)titanium) oxide as a 4-oxo-type chiral
Lewis Acid:ꢀ application to catalytic asymmetric allylation of alde-
hydes. J. Am. Chem. Soc., 2003, 125, 1708-1709; b) Das, B.;
Shinde, D. B.; Kanth, B. S.; Kamle, A.; Kumar, C. G. Total synthe-
sis of racemic and (R) and (S)-4-methoxyalkanoic acids and their
antifungal activity. Eur. J. Med. Chem., 2011, 46, 3124-3129.
Grubbs, R. H.; Miller, S. J.; fu, G. C. Ring-closing metathesis and
related processes in organic synthesis. Acc. Chem. Res., 1995, 28,
446-452.
Enders, D.; Dhulut, S.; Steinbusch, D.; Herrbach, A. Asymmetric
total synthesis of (ꢄ)-pironetin employing the SAMP/RAMP
hydrazone methodology. Chem. Eur. J., 2007, 13, 3942-3949.
Nakamura, S.; Inagaki, J.; Kudo, M.; Sugimoto, T.; Obara, K.;
Nakajima, M.; Hashimoto, S. Studies directed toward the total syn-
thesis of pinnatoxin A: synthesis of the 6,5,6-dispiroketal (BCD
1-triphenylphosphoranylidene -4-phenylbutan-2-one (17)
(0.41 g, 1.28 mmol) was added to a solution of aldehyde 1
(0.10 g, 0.72 mmol) in benzene (10 mL) and the reaction
content was refluxed for 14 h. After cooling, the solvent was
evaporated under reduced pressure and the crude product
(1.42 g, yellow solid) was purified using column chromatog-
raphy (ethyl acetate/hexane 1:8) to give (R, E)-6-(4-oxo-6-
phenylhex-2-enyl)-5,6-dihydropyran-2-one (rugulactone) (4)
(0.14 g, 72%) as a colorless oil. The optical rotation of the
[2]
[3]
25
compound was [ꢀ]D = - 34.2 (c = 1.0, CHCl3); IR: 1722,
1
1676, 1639, 1437, 1362, 1247 cm1; H NMR (CDCl3, 200
MHz): ꢁ 7.30-7.22 (2H, m),7.20-7.14 (3H, m), 6.85 (1H, m ),
6.79 (1H, m ), 6.19 (1H, d, J = 16.0 Hz), 6.04 (1H, d, J = 9.0
Hz), 4.55 (1H, m), 2.98-2.85 (4H, m), 2.71-2.57 (2H, m),
2.38-2.29 (2H, m); 13C NMR (CDCl3, 50 MHz): ꢁ 199.2,
165.2, 141.0, 140.8, 132.5, 130.6, 128.0, 127.8, 125.7, 119.2,
71.3, 40.8, 34.6, 35.8, 30.0; ESIMS: m/z 271 [M+H]+..
[4]
[5]
(S, E)-6-(4-oxo-6-phenylhex-2-enyl)-5,6-dihydropyran-2-
one [(S)-Rugulactone] (4a)
Compound 12a (0.40 g, 2.82 mmol) dissolved in dry
DCM (5 mL) was slowly added to a solution of IBX (1.20 g,
2.82 mmol) in dry DMSO (2.5 mL) at room temperature and
was stirred for 2 h. After completion, ice cold water (2 mL)
was added to the reaction and the mixture extracted into
DCM (3 x 10 mL). The organic layer was dried over Na2SO4
and concentrated under reduced pressure. The crude product
was subjected to column chromatography (ethyl ace-
tate/hexane, 1:9). The purified aldehyde 1a (0.32 g, 80%)
was directly subjected to further reaction.
[6]
[7]
[8]
1-triphenylphosphoranylidene -4-phenylbutan-2-one (17)
(0.41 g, 1.28 mmol) was added to a solution of aldehyde 1a
(0.10 g, 0.72 mmol) in benzene (10 mL) and the reaction
content was refluxed for 14 h. After cooling, the solvent was
evaporated under reduced pressure, and the crude product
(1.42 g, yellow solid) was purified using column chromatog-
raphy (ethyl acetate/hexane 1:8) to give (S, E)-6-(4-oxo-6-
[9]
[10]
[11]
[12]
phenylhex-2-enyl)-5,6-dihydropyran-2-one
(rugulactone)
(4a) (0.14 g, 72%) as a colorless oil. The optical rotation of
25
the compound was [ꢀ]D = + 35.4 (c = 1.0, CHCl3). The
spectral data (Proton NMR, Carbon NMR and MS) of 4a
were found to be identical as those of 4.
CONFLICT OF INTEREST
[13]
[14]
The author(s) confirm that this article content has no con-
flict of interest.
ACKNOWLEDGEMENTS
The authors thank CSIR and UGC, New Delhi for finan-
cial assistance.
[15]
[16]
[17]
REFERENCES
# Part 52 in the series, “Synthetic studies on natural
products”.
[1]
a) Rychnovsky, S. D. Total synthesis of bioactive marine macrol-
ides. Chem. Rev., 1995, 95, 2021-2040; b) Drewes, S. E.; Sehla-
pelo, B. M.; Horn, M. M.; Scott-Shaw, R.; Sandor, O. 5,6-Dihydro-